Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • BP

    Tag: BP

    You Searched For "BP"
    Health Ministry, WHO join hands to redesignate NHSRC for development of medical devices

    Health Ministry, WHO join hands to redesignate NHSRC for development of medical devices

    Farhat Nasim4 Oct 2019 5:06 PM IST
    This year in collaboration with WHO's country office, NHSRC developed a guidance document for the health ministry's free diagnostics initiative to...
    Dr Reddys suspends worldwide supply of Ranitidine over cancer fears until USFDA probe over

    Dr Reddys suspends worldwide supply of Ranitidine over cancer fears until USFDA probe over

    Medical Dialogues Bureau23 Sept 2019 10:00 AM IST
    Ranitidine is an Over-The-Counter (OTC) and prescription drug which decreases the amount of acid created by the stomach.Hyderabad: Dr Reddy's...
    NPPA fixes retail price of 10 combo drugs including Metformin, Rosuvastatin; Details

    NPPA fixes retail price of 10 combo drugs including Metformin, Rosuvastatin; Details

    Farhat Nasim16 Aug 2019 4:01 PM IST
    New Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
    Lupin, Zydus Cadila recall products in US; includes BP drug Carvedilol

    Lupin, Zydus Cadila recall products in US; includes BP drug Carvedilol

    Farhat Nasim6 May 2019 10:00 AM IST
    Lupin Somerset is recalling 46,700 bottles of Morphine Sulfate extended-release tablets in various strengths due to "failed impurities/degradation...
    Zydus Cadila gets USFDA nod for Phentermine Hydrochloride orally disintegrating tablets

    Zydus Cadila gets USFDA nod for Phentermine Hydrochloride orally disintegrating tablets

    Medical Dialogues Bureau26 April 2019 8:59 AM IST
    Phentermine Hydrochloride orally disintegrating tablets is used together with diet and exercise to treat obesity (overweight) in people with risk...
    Omron Healthcare to introduce COMPLETE, first BP monitor with EKG capability

    Omron Healthcare to introduce COMPLETE, first BP monitor with EKG capability

    Farhat Nasim15 April 2019 9:20 AM IST
    Complete is an upper arm blood pressure (BP) monitor that allows users to simultaneously monitor EKG and blood pressure readings at home. U.S: Omron...
    Amazon Alexa to now help in health care; store BP measurement, book medical appointment, check prescription delivery

    Amazon Alexa to now help in health care; store BP measurement, book medical appointment, check prescription delivery

    Medical Dialogues Bureau8 April 2019 9:40 AM IST
    Amazon announced that its Alexa-enabled devices can now handle customers' sensitive medical data. A new kit will allow approved developers to build...
    Valsartan Shortage: Alkem Labs gets USFDA nod to generic Diovan

    Valsartan Shortage: Alkem Labs gets USFDA nod to generic Diovan

    Farhat Nasim13 March 2019 1:49 PM IST
    Valsartan, sold under the trade name Diovan among others, is a medication used to treat high blood pressure, heart failure, and diabetic kidney...
    Lupin posts Q3 loss of Rs 152 crore on litigation over Perindopril

    Lupin posts Q3 loss of Rs 152 crore on litigation over Perindopril

    Farhat Nasim7 Feb 2019 2:23 PM IST
    Lupin had a net loss of 1.52 billion rupees compared to a profit of 2.22 billion rupees in the same quarter last year, the company said.Mumbai: A...
    Healthians to expand in South India, invests Rs 50 crore

    Healthians to expand in South India, invests Rs 50 crore

    Farhat Nasim13 Jan 2019 9:30 AM IST
    "Based on our market survey and customer demand, South India is our first move for a mega expansion planned in 2019," Deepak Sahni, Founder and CEO of...

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok